Transcutaneous immunostimulation

Details for Australian Patent Application No. 2002252378 (hide)

Owner Iomai Corporation

Inventors Six, Howard R.; Glenn, Gregory M.

Agent Spruson & Ferguson

Pub. Number AU-B-2002252378

PCT Pub. Number WO2002/074244

Priority 60/276,496 19.03.01 US

Filing date 19 March 2002

Wipo publication date 3 October 2002

Acceptance publication date 18 October 2007

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

Event Publications

27 March 2003 Application Open to Public Inspection

  Published as AU-B-2002252378

18 October 2007 Application Accepted

  Published as AU-B-2002252378

14 February 2008 Standard Patent Sealed

20 November 2008 Alteration of Name

  The name of the patentee has been altered to Intercell USA, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002252379-METHOD OF TREATMENT OF DREDGED MATERIAL FOR BENEFICIAL USE

2002252377-METHOD FOR CURING SELFREDUCING AGGLOMERATES